Relapsed Stage 3–4 Lung Cancer Not Shrinking on Second-Line Treatment and Weight Down From 87 to 40 kg: Biomarker Re-testing, Treatment Options, Cancer Cachexia, Neck Stiffness With Swallowing Trouble, and Stress

From a cancer patient support group: the second round of treatment is not shrinking the tumor, weight is down to 40 kg, the neck tilts, and swallowing is hard. What now?

Direct answer: there are still several things that can be done — biomarker re-testing to look for new drug options, serious nutrition rebuilding, finding the cause of neck tilt and swallowing trouble,
and palliative care alongside treatment so body and mind have strength to keep going.

A member of a cancer patient support group shared that after stage 3–4 lung cancer treatment, follow-up visits were every 3 months and work resumed for about 6 months before the disease spread elsewhere.
The second treatment left the neck and back feeling pulled after repeated radiation, with neck tilt, weakness, and difficulty swallowing. Weight fell from 87 kg before diagnosis to 60, then 45, and now 40 kg,
while working through treatment, worrying about costs, and fearing that stress was stopping the drugs from working. This article summarizes the evidence so patients and families can talk with the treating doctor.

1. Why second-line treatment is not shrinking the tumor, and biomarker re-testing for new options

Direct answer: cancer cells that survive the first treatment are often drug-resistant and respond less to later lines. The next option depends on three things: biomarker results, previous drugs, and physical strength.

Re-testing biomarkers: tissue or blood

ESMO 2023 guidelines for
oncogene-addicted lung cancer
and
non-oncogene-addicted lung cancer
recommend testing key genes such as EGFR, ALK, ROS1, BRAF, KRAS G12C, MET, RET, NTRK, and HER2 together with PD-L1. If testing was incomplete or the disease has changed, ask about re-testing.
The 2021 IASLC consensus
says a blood test (liquid biopsy) is useful when a biopsy is difficult or risky; a positive result can guide treatment, but a negative one should prompt consideration of tissue confirmation.

Physical strength matters as much as the drug

Doctors use performance status (ECOG) to judge how well a person manages daily activities. People in bed more than half the day often get more harm than benefit from chemotherapy,
while some targeted drugs can still be used in weaker patients if a target gene is present. Rebuilding nutrition and controlling symptoms are therefore part of getting the body ready for treatment.

Options after second-line treatment compared using generic names and drug classes only (cards on mobile)

Palliative care alongside treatment is not giving up

Temel’s 2010 NEJM trial
randomized 151 people with metastatic non-small-cell lung cancer. Those who received early palliative care alongside cancer treatment had better quality of life,
fewer depressive symptoms (16% vs 38%), and longer median survival (11.6 vs 8.9 months), despite less aggressive end-of-life care.

2. Cancer cachexia: why weight keeps falling despite eating, and how to rebuild

Direct answer: falling from 87 to 40 kg (about 54%) is severe cachexia and needs urgent dietitian or nutrition support team care, not just buying supplements.

Definition and mechanism

The international consensus (Fearon 2011)
defines cancer cachexia as ongoing muscle loss that ordinary nutrition cannot fully reverse. The criterion is weight loss over 5%, or over 2% in people already thin or low in muscle.
It progresses from precachexia to cachexia to refractory cachexia, driven by both reduced intake and inflammatory signals from the cancer that speed muscle breakdown.

Energy and protein targets

• About 25–30 kcal per kilogram per day and more than 1, up to 1.5, grams of protein per kilogram per day, per the ESPEN 2021 guideline
• 6–8 small meals a day, focusing on eggs, fish, tofu, milk or yogurt, with added energy from vegetable oil or ground nuts
• Oral nutritional supplements (ONS) between meals, with the formula chosen by a dietitian for other conditions such as diabetes or kidney disease
• If swallowing trouble keeps intake below target despite adjustments, discuss tube feeding in line with care goals
• Very thin patients need gradual increases and blood tests for electrolytes because of refeeding syndrome risk (low phosphate, potassium, magnesium)
• Gentle movement as strength allows, such as walking at home and arm and leg lifts, helps keep remaining muscle

Appetite medicines: limited benefit

The ASCO 2020 guideline
says no drug is a standard of care for cachexia, but if a doctor decides to try one, the options with evidence are progesterone analogs such as megestrol acetate (raises clot risk)
and short-term corticosteroids for a few weeks. Anamorelin, a ghrelin-receptor agonist, in
the ROMANA 1 and 2 trials
increased lean body mass by 0.99 and 0.65 kg over 12 weeks but did not improve handgrip strength, and it is not available in every country.

Stages of cancer cachexia and how to manage them (cards on mobile)

Fish oil (EPA/DHA) has limited evidence and ASCO does not recommend it as standard. Check with the doctor before combining it with cancer treatment, and avoid herbal products not cleared by the care team.

3. Neck stiffness, neck tilt, and swallowing trouble: find the cause, then rehabilitate

Direct answer: fibrosis after repeated radiation can genuinely stiffen and tilt the neck, but in spreading cancer spread to the neck spine, esophageal narrowing, and vocal cord nerve palsy must be ruled out first, because treatments differ greatly.

Stubblefield’s review (2011)
explains that radiation fibrosis gradually hardens tissue and damages muscles and nerves, causing neck dystonia (cervical dystonia) and weakness, and that rehabilitation physicians play a key role in restoring function.

Common causes of neck tilt and swallowing trouble in relapsed lung cancer (cards on mobile)

Swallowing safely while waiting for assessment

• Sit upright, tuck the chin slightly when swallowing, and stay upright for at least 30 minutes after eating
• Soft, moist, or pureed foods; thin liquids that cause choking may need thickening as advised
• Small bites, eat slowly, do not talk while swallowing
• Keep the mouth clean to reduce germs that could be inhaled into the lungs

4. Stress and treatment response, and getting support with treatment rights

Direct answer: a tumor that does not shrink is not the patient’s fault. Research shows only an association and does not prove stress makes drugs fail, but less burden and more rest help with eating, sleeping, and tolerating treatment.

Chida’s meta-analysis (2008)
linked stress-related factors with poorer survival in several cancers including lung cancer, but the authors warned of publication bias and urged caution.
Stress may reduce eating and sleep and lead to missed appointments, which acts indirectly rather than making cancer cells resistant directly.

• Ask the hospital social worker about treatment coverage under your health scheme, which drugs are covered, travel costs, and cancer patient foundations
• Talk with your employer about sick leave or adjusted duties, and ask about sickness or disability benefits available to you
• Ask to see a psycho-oncology psychologist or psychiatrist for ongoing stress, low mood, or insomnia
• Ask for palliative care referral alongside treatment for pain, breathlessness, poor appetite, and advance care planning
• Let family share tasks such as writing questions for appointments, preparing food, and transport

Frequently asked questions (FAQ)

Questions people with relapsed lung cancer and their families often ask

Why does relapsed lung cancer stop shrinking on second-line treatment?

The main reason is drug resistance. When the disease returns, the cells that survived the first treatment often carry genetic changes that make them respond less to the same or similar drugs, and tumors in different sites can behave differently. A tumor that does not shrink reflects cancer biology, not the patient’s fault. The next step is to ask the treating doctor about biomarker re-testing and which later-line treatment fits current physical strength.

Should biomarkers be re-tested, and can a blood test replace a tissue biopsy?

Ask the treating doctor, especially if comprehensive testing was never done or the disease has changed after treatment. ESMO 2023 guidance recommends testing key genes such as EGFR, ALK, ROS1, BRAF, KRAS G12C, MET, RET, NTRK, and HER2 along with PD-L1. The 2021 IASLC consensus says a blood test (liquid biopsy) is useful when tissue is hard or risky to obtain, and a positive result can guide treatment, but a negative blood result should prompt consideration of a tissue biopsy.

Are targeted therapy and immunotherapy suitable for everyone?

No. Targeted therapy works well only when a target gene such as EGFR or ALK is found; without one it does not help. Many patients already received immunotherapy in first-line treatment, and it can cause immune-related inflammation that differs from chemotherapy side effects rather than always being milder. Doctors choose based on biomarker results, previous drugs, and performance status, because very weak patients may get more harm than benefit.

How should nutrition be rebuilt after weight falls from 87 to 40 kg?

Falling from 87 to 40 kg is a loss of about 54 percent, which is very severe, so ask for a dietitian or nutrition support team soon. ESPEN guidance suggests about 25–30 kcal per kilogram per day and more than 1, up to 1.5, grams of protein per kilogram per day, using small frequent meals and oral nutritional supplements. If swallowing trouble prevents enough intake, discuss tube feeding. In very thin patients, feeding must be increased gradually under supervision because of the electrolyte risk of refeeding syndrome.

Are there medicines that improve appetite or weight?

Yes, but their benefit is limited. The ASCO 2020 guideline says no drug is a standard of care; if a doctor decides to try one, the options with evidence are progesterone analogs such as megestrol acetate, which raises clot risk, and short-term corticosteroids for a few weeks. In the ROMANA trials, anamorelin increased lean body mass by about 0.65–0.99 kg over 12 weeks but did not improve handgrip strength, and it is not available in every country. Do not buy weight-gain drugs or steroids on your own.

How can neck tilt, neck stiffness, and swallowing trouble after repeated radiation be relieved?

These symptoms may come from radiation fibrosis, which tightens and tilts the neck muscles, but in spreading cancer a doctor must first rule out other causes such as spread to the neck spine, radiation-related inflammation or narrowing of the esophagus, lymph nodes pressing on the esophagus, or vocal cord nerve palsy causing choking. Once those are excluded, a rehabilitation physician or physiotherapist teaches gentle neck stretching, pain is controlled, and a speech and swallowing therapist assesses swallowing and adjusts food texture for safety.

Does stress really make cancer treatment fail?

A 2008 meta-analysis by Chida found an association between stress and poorer survival, but the studies were observational with publication bias and did not prove that stress makes drugs fail. Resistance comes mainly from cancer cell biology, so patients should not blame themselves. Reducing stress and getting rest still help with eating, sleeping, and tolerating treatment, so ask to see a psychologist or palliative care team, and a social worker about treatment rights and costs.

Does palliative care mean stopping treatment?

No. Palliative care can run alongside cancer treatment to control pain, breathlessness, poor appetite, and distress. In Temel’s 2010 NEJM trial of metastatic non-small-cell lung cancer, early palliative care improved quality of life, reduced depressive symptoms from 38 to 16 percent, and was linked to longer median survival of 11.6 versus 8.9 months.

Scientific mechanism (brief)

Summary by Asst. Prof. Dr. Norawit Raatpiboon:
a tumor contains many cell groups with different genetics. First-line drugs kill sensitive groups, while resistant groups or newly mutated cells survive and take over, which is why re-testing checks whether the driver has changed.
In cachexia, tumor and immune cells release inflammatory signals such as IL-6 and TNF-α that suppress appetite through the hypothalamus and switch on the ubiquitin-proteasome system in muscle to break down protein, while fat is burned faster, so food alone cannot fully reverse it.
Radiation damages small blood vessels and triggers TGF-β, prompting fibroblasts to lay down collagen that hardens into fibrosis over years, tightening and tilting the neck muscles and disturbing swallowing.

Read next: related guides